Skip to main content

Table 2 IMP diagnoses influenced real-world intervention and surveillance decisions that were of benefit to patients (total N = 491)

From: Influence of integrated molecular pathology test results on real-world management decisions for patients with pancreatic cysts: analysis of data from a national registry cohort

Initial ICG recommendation

Initial IMP diagnosis

Patients who had clinical intervention at follow-up in reality

Patients who had surveillance at follow-up in realitya

n

Surgery rate, %

Malignant outcome rate, %

n

Surveillance rate, %

Benign outcome rate, %

Surveillance

Low risk (n = 195)

33

17

3

162

83

99

High risk (n = 8)

7

88

57

1

12

100

Surgery

Low risk (n = 202)

90

45

9

112

55

99

High risk (n = 86)

76

88

66

10

12

100

  1. aMedian follow-up time 2.9 years (range, 1.9 to 7.7 years)